14th European Congress of Clinical Microbiology and Infectious ...
14th European Congress of Clinical Microbiology and Infectious ...
14th European Congress of Clinical Microbiology and Infectious ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Poster Sessions Sunday, May 2, 2004<br />
P516 Antifungal activity <strong>of</strong> Juniperus turbinata on<br />
species <strong>of</strong> C<strong>and</strong>ida <strong>and</strong> dermatophytes<br />
E. Pinto, C. Cavaleiro, L. Salgueiro, A. Palmeira,<br />
M. Gonçalves, C. Pina-Vaz, A. Gonçalves<br />
Rodrigues, S. Costa-de-Oliveira, C. Tavares,<br />
J. Martinez-de-Oliveira (Porto, Coimbra, P)<br />
P517 The effect <strong>of</strong> onion extract on ultrastructure<br />
<strong>of</strong> Trichophyton mentagrophytes <strong>and</strong><br />
T. rubrum<br />
M. Shams, M. Godarzi, T. Tarihi, M. Razzaghi<br />
Abyaneh (Tehran, IR)<br />
P518 Effects <strong>of</strong> 5-hydroxytryptamine on virulence<br />
properties <strong>of</strong> C<strong>and</strong>ida albicans in vitro<br />
A. Mayr, G. Hinterberger, M.-P. Dierich,<br />
C. Lass-Flörl (Innsbruck, A)<br />
P519 Studies on in vitro antimicrobial activity <strong>of</strong><br />
vitreous substitutes against C<strong>and</strong>ida albicans<br />
A. Szczepanik, E. Kosior-Jarecka, M. Wojtowicz,<br />
J. Mackiewicz, M. Koziol-Montewka (Lublin, PL)<br />
P520 Antifungal resistance patterns among oral<br />
C<strong>and</strong>ida species from patients receiving<br />
anticancer therapy<br />
I. Glazar, M. Abram, S. Pezelj-Ribaric, B. Miletic,<br />
I. Brekalo Prso, B. Matica (Rijeka, Zagreb, HR)<br />
12:00–13:00<br />
Antibiotic resistance in respiratory pathogens<br />
P521 Changes in macrolide susceptibility <strong>of</strong> oral<br />
streptococci following administration <strong>of</strong><br />
azithromycin or clarithromycin to healthy<br />
volunteers – A prospective r<strong>and</strong>omised<br />
blinded trial<br />
J. Wagner, C. Klaus, H. Orawa, M. Pletz,<br />
M. Eisenblatter, W.E. Haefeli, H. Hahn, H. Lode<br />
(Berlin, Heidelberg, D)<br />
P522 Unchanged susceptibility <strong>of</strong> key respiratory<br />
pathogens to telithromycin post-introduction<br />
in Germany<br />
R. Reinert, A. Rodl<strong>of</strong>f, D. Felmingham<br />
The PROTEKT Study Group<br />
P523 Prevalence <strong>of</strong> antimicrobial resistance <strong>and</strong><br />
activity <strong>of</strong> the ketolide telithromycin against<br />
Haemophilus influenzae isolated from<br />
Japanese children<br />
K. Sunakawa, D. Farrell (Kanagawa, JP; London, UK)<br />
P524 Susceptibility <strong>of</strong> recent paediatric respiratory<br />
isolates <strong>of</strong> Streptococcus pneumoniae <strong>and</strong><br />
Haemophilus influenzae in Spain<br />
C. Latorre, C. Garcia-Rey, J. Barron, A. Pinedo,<br />
J.M. Nogueira, J. Torres, L. Aguilar – The Spanish<br />
Surveillance Group for Respiratory Pathogens<br />
page 70 Final Programme<br />
P525 Susceptibility <strong>of</strong> Haemophilus influenzae<br />
respiratory isolates from adults in Spain<br />
(2001–2002)<br />
A. Garcia-Perea, C. Garcia-Rey, C. Garcia-Riestra,<br />
R. L<strong>and</strong>inez, M. De-la-Rosa, P. Alomar,<br />
J. Garcia-de-Lomas, L. Aguilar – The Spanish<br />
Surveillance Group for Respiratory Pathogens<br />
P526 Antibiotic sensitivity <strong>of</strong> streptococci isolated<br />
in ear, nose <strong>and</strong> throat diseases – development<br />
<strong>of</strong> resistance from 1999 to 2002/2003<br />
K. Fickweiler, U. Fickweiler, A.C. Rodl<strong>of</strong>f<br />
(Leipzig, D)<br />
P527 The comparative in vitro activity <strong>of</strong><br />
moxifloxacin against respiratory tract<br />
pathogens isolated during 2003 from Libra<br />
Targeted Surveillance<br />
I. Morrissey, A. Colclough, L. Viljoen, K. Dowling,<br />
M. McKeon, T. Veltman (London, UK)<br />
12:00 – 13:00<br />
New drugs <strong>and</strong> novel therapeutic approaches<br />
P528 In vitro activity <strong>of</strong> synthetic peptides <strong>and</strong><br />
mechanisms <strong>of</strong> resistance to colistin in<br />
pan-resistant Acinetobacter baumannii<br />
M. Rodriguez, J. Saugar, F. Docobo-Perez,<br />
J. Paneque, M.E. Pachón-Ibañez, J. Aznar,<br />
D. Andreu, L. Rivas, J. Pachón<br />
(Seville, Madrid, Barcelona, E)<br />
P529 New antimicrobial peptide active against<br />
methicillin-resistant Staphylococcus aureus,<br />
multiresistant coagulase negative staphylococci,<br />
<strong>and</strong> beta-haemolytic streptococci<br />
A. Jasir, F Kasprzykowski, V. Lindstrom,<br />
C. Schalen, A. Grubb (Lund, S; Gdansk, PL)<br />
P530 Comparison <strong>of</strong> azithromycin <strong>and</strong> amoxicillin<br />
for treatment <strong>of</strong> adult patients with solitary<br />
erythema migrans<br />
S. Lotric-Furlan, M. Logar, V. Maraspin,<br />
J. Cimperman, T. Jurca, F. Strle (Ljubljana, SI)<br />
P531 Comparative in vitro activity <strong>of</strong> ABT-492 <strong>and</strong><br />
six other antimicrobial agents against<br />
anaerobic bacteria<br />
E. Sillerström, E. Wahlund, C.E. Nord (Stockholm, S)<br />
P532 Iclaprim, a novel diaminopyrimidine<br />
antibiotic: synergy studies with different<br />
classes <strong>of</strong> antibiotics<br />
L. Weiss, D. Gillessen, S. Hawser, K. Islam<br />
(Munchenstein, CH)
Change language